Canaccord Genuity analyst Edward Nash maintained a Hold rating on Intercept Pharma (ICPT – Research Report) yesterday and set a
Tag: Intercept Pharma
Leerink Partners Keeps Their Hold Rating on Intercept Pharma (ICPT)
Leerink Partners analyst Thomas Smith reiterated a Hold rating on Intercept Pharma (ICPT – Research Report) on February 25. The
Needham Thinks Intercept Pharma’s Stock is Going to Recover
In a report released today, Joseph Stringer from Needham maintained a Buy rating on Intercept Pharma (ICPT – Research Report),
Wedbush Thinks Intercept Pharma’s Stock is Going to Recover
Wedbush analyst Liana Moussatos reiterated a Buy rating on Intercept Pharma (ICPT – Research Report) today and set a price
Chardan Capital Keeps a Buy Rating on Intercept Pharma (ICPT)
In a report released yesterday, Michael Morabito from Chardan Capital maintained a Buy rating on Intercept Pharma (ICPT – Research
Robert W. Baird Thinks Intercept Pharma’s Stock is Going to Recover
Robert W. Baird analyst Brian Skorney maintained a Buy rating on Intercept Pharma (ICPT – Research Report) on February 25
Analysts Offer Insights on Healthcare Companies: Intercept Pharma (NASDAQ: ICPT) and Fortress Biotech (NASDAQ: FBIO)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intercept Pharma